Today the colleague was there again who had to take early retirement because of Longcovid and was completely cognitively and physically switched off and “came back to life” 15 minutes after being given a blood thinner.
I found out about this triple therapy on Reddit, in the USA the main representative of this therapy is Dr. Jordan Vaughn, about whom I gave several links in my first article:
Here I have another one of the Pubmed – Article read about it and because of the really amazing success with my patient – which is confirmed in this article below – translated into German:
Treatment of Long COVID symptoms with triple anticoagulant therapy, Gert Laubscher et al 2023,
This working group led by Gert Laubscher has many studies in the Pubmed on the topic
Abstract (=summary) of the article
Background:
Fibrin(ogen)-amyloid microclots and platelet hyperactivation are important pathological findings in patients with acute COVID-19 infection and also in patients with long-COVID/post-acute sequelae COVID-19 (PASC). These pathologies may represent a suitable target for pharmacological treatment of LongCOVID
-
- These micro clots can be deposited as amyloid deposits in the heart or larger blood vessels –> see clots from embalmers in the US on Odyssey and then lead to “sudden death” like he is currently experiencing is observable. This can also take place as NW during spiking, with Astra-Zeneka-xRMA I+mpfng it was even recognized in the mainstream media at the time that some women died of blood clots in the brain.
- here the Original article on Epoch-Times Unfortunately, due to the agenda-driven censorship in the leading media, this can no longer be found in search-machines – here they only stonewall or only present distracting articles. Twitter, Telegram, Odysee and Rumble are the only uncensored news platforms – Google and YouTube are completely agenda-driven and, like Wikipedia, are no longer credible when it comes to the pandemic and Pharma.
Methods:
Here we report the symptoms of a cohort of 91 South African Long COVID patients at baseline and after completion of physician-initiated anticoagulant treatment.
For laboratory
For analysis, patients provided a blood sample before and after treatment. Presence of fibrinaloid microclots was examined by adding thioflavin T to platelet-poor plasma (PPP), while we examined platelet hyperactivation of two platelet markers – PAC1 and CD62P (P-selectin). .
The anticoagulant treatment consisted of a
- dual antiplatelet therapy (DAPT-clopidogrel 75 mg + aspirin 75 mg) once daily
- and a direct oral administration of anticoagulant (DOAC-Apixaban = Eliquis (r)) 5 mg twice daily.
- A proton pump inhibitor (PPI) Pantoprazole 40 mg/day was also prescribed for gastric protection.
Each of the cases treated reported their main long-COVID symptoms and whether or not their symptoms resolved after treatment.
Results
In our cohort, most participants reported no comorbidities prior to acute COVID-19 infection.
Hypertension and dyslipidemia were the most common underlying diseases and also the most common.
Commonly reported Long COVID symptoms included
- Fatigue,
- cognitive dysfunction,
- Shortness of breath,
- and joint and muscle pain.
After completion of treatment, each of the various symptoms disappeared in the majority of patients.
This was also reflected in theLaboratory analysis reflected where a decrease in the severity of fibrin-amyloid microcoagulation and the degree of platelet pathology was noticeable.
No adverse bleeding events were reported.
Conclusions
- Fibrin-amyloid microclots,
- Platelet hyperactivation/aggregation and widespread
- Endothelialitis
inhibits oxygen transport at the capillary/cellular level.
This provides an explanation for the symptoms of Long COVID, with normalization of the failed coagulation physiology leading to a reversal of the symptoms.
In endothelialitis, triple anticoagulant therapy appears to represent a promising treatment option that is highly effective and would warrant controlled clinical trials.
We caution that such a regimen should only be followed under expert medical supervision due to the risk of bleeding.
This is correct, if bleeding occurs during this therapy, it can hardly be stopped! So far I have only carried out double therapy with Eliquis + ASS with clear symptoms and increased D-dimer, as this is a “commercially available” blood thinner for cardiac indications and hundreds of thousands of patients have received this from an internist.
Cover photo
(c) NTD news photographed from ODYSEE contribution</ a>
Google CENSORSHIP!
Google censors my homepage quite a bit, sometimes I am not even able to find my articles on Google. So please sign up for the newsletter and share it with friends or via Facebook and use the search function on my website. Follow me on Twitter, where I also announce important articles.